Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio change
Portfolio Pulse from
Evaxion Biotech A/S has announced an extension to January 14, 2025, for the implementation of a change in the ratio of its American Depositary Shares (ADS) from 1 ADS representing 10 ordinary shares to 1 ADS representing 50 ordinary shares.
January 10, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Evaxion Biotech is extending the date for its ADS ratio change to January 14, 2025. The new ratio will be 1 ADS for 50 ordinary shares, which could impact the stock's liquidity and price.
The change in ADS ratio from 1:10 to 1:50 could affect the stock's liquidity and price. However, the extension of the implementation date suggests no immediate impact, leading to a neutral short-term outlook.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100